Serum kisspeptin levels in Korean girls with central precocious puberty.
Rhie. Young Jun YJ; Lee. Kee Hyoung KH; Eun. So Hee SH; Choi. Byung Min BM; Chae. Hyun Wook HW; Kwon. Ah Reum AR; Lee. Woo Jung WJ; Kim. Jung Hyun JH; Kim. Ho-Seong HS
Key Findings
- Girls with central precocious puberty had significantly higher serum kisspeptin (4.61â¯Â±â¯1.78â¯pM/L) than ageâmatched controls (2.15â¯Â±â¯1.52â¯pM/L).
- Serum kisspeptin positively correlated with peak LH, the peak/basal LH ratio, and the peak LH/FSH ratio during GnRH stimulation.
- The authors propose kisspeptin as a potential diagnostic marker for early puberty and call for further genetic studies.
Practical Outcomes
- For most biohackers, this study offers limited direct action because it focuses on a pediatric condition. It does highlight that kisspeptin levels rise before puberty, which could inform future research on hormonal timing, but thereâs no immediate protocol or dosage recommendation for adult health optimization.
Summary
Researchers measured kisspeptin levels in Korean girls with early-onset puberty and found they were about twice as high as in normal preâpubertal girls. Higher kisspeptin was linked to stronger hormone responses that trigger puberty, suggesting it could be a useful blood marker for spotting early puberty.
Abstract
Central precocious puberty (CPP) is caused by premature activation of hypothalamic gonadotropin-releasing hormone (GnRH) secretion. Kisspeptin and G-protein coupled receptor-54 system is the essential gatekeeper of the reproductive system, playing a key role in the activation of the gonadotropic axis at puberty. We aimed to determine whether serum kisspeptin may function as a marker for CPP by investigating serum kisspeptin levels in Korean girls with CPP and their prepubertal controls. Serum kisspeptin levels of Korean girls with CPP (n = 30) and age-matched healthy prepubertal controls (n = 30) were measured with a competitive enzyme immunoassay. Serum kisspeptin levels were significantly higher in CPP group than in control group (4.61 ± 1.78 vs 2.15 ± 1.52 pM/L, P < 0.001). Serum kisspeptin was positively correlated with peak luteinizing hormone (LH), peak/basal LH ratio and peak LH/follicular-stimulating hormone (FSH) ratio during GnRH stimulation test. CPP is supposed to be triggered by premature increase of kisspeptin. Serum kisspeptin may be used as a marker of CPP. Further studies on KISS1 gene polymorphisms leading to higher risk of premature increase of kisspeptin and upstream regulator of kisspeptin are also needed.
Study Information
pubmed
2011
2011-06-20T00:00:00.000Z
10.3346/jkms.2011.26.7.927
56
29